Table 1.

Characteristics of ovarian cancer patients who participated in this study (n = 13)

	HR(−) group	HR(+) group	P-value
No. of patients	8	5	–
Age, years†	57.5 (50–73)	61 (54–69)	0.30
No. of CBDCA treatments prior to study†	7 (7–8)	14 (11–22)	<0.01
History of drug/food allergy‡	4	3	1.00
Dose of CBDCA during study, mg†	575 (400–690)	500 (150–700)	0.66

–, not applicable; CBDCA, carboplatin; HR, hypersensitivity reaction.

^†Data are expressed as median values (minimum–maximum), and statistical analyses between the two groups were carried out using the Mann–Whitney U-test.

^‡Statistical analyses between the two groups were carried out using Fisher's exact test.